Mediwound ltd. (MDWD)
CashFlow / Quarterly
Jun'18Jun'17
Cash Flows from Operating Activities:
Net loss

-4,165

-4,462

Adjustments to reconcile net loss to net cash used in continuing operating activities:
Adjustments to profit and loss items:
Loss from discontinued operation

0

0

Depreciation and amortization

170

146

Share-based compensation

149

337

Revaluation of liabilities in respect of IIA grants

-218

-221

Revaluation of contingent consideration for the purchase of shares

569

570

Increase (decrease) in severance liability

-5

12

Net financing income

115

88

Un-realized foreign currency (gain) loss

-85

39

Adjustments to profit and loss items, total

1,071

1,159

Changes in asset and liability items:
Decrease (increase) in trade receivables

-494

-201

Decrease (increase) in inventories

149

-132

Decrease (increase) in other receivables

-1,690

278

Increase (decrease) in trade payables

-51

-2,487

Increase (decrease) in other payables and deferred revenues

-507

1,606

Changes in asset and liability items, total

-2,593

-936

Net cash flows used in operating activities

-5,687

-4,239

Net cash used in discontinued operating activities

0

0

Net cash used in operating activities

-5,687

-4,239

Cash Flows from Investing Activities:
Purchase of property and equipment

197

169

Purchase of intangible assets

13

0

Interest received

2

12

Proceeds from (investment in) short term bank deposits, net

1,680

3,007

Net cash provided by (used in) investing activities

1,472

2,850

Cash Flows from Financing Activities:
Proceeds from exercise of options

0

2

Proceeds from issuance of shares, net

0

0

Proceeds from IIA grants, net of repayments

0

-65

Net cash provided by (used in) financing activities

0

-63

Exchange rate differences on cash and cash equivalent balances

-117

76

Increase (decrease) in cash and cash equivalents from continuing activities

-4,332

-1,376

Decrease in cash and cash equivalents from discontinued activities

0

0